WARRANT TO PURCHASE SHARES OF COMMON STOCK SOLIGENIX, INC.Soligenix, Inc. • July 9th, 2024 • Pharmaceutical preparations
THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, [__], or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 10, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Soligenix, Inc., a Delaware corporation (the “Company”), up to [__] shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
CONFIDENTIAL Soligenix, Inc. Princeton, NJ 08540 Attention: Dr. Christopher J. Schaber Ph.D., CEO Re: Soligenix, Inc.– Financial Advisory Agreement Dear Dr. Schaber,Soligenix, Inc. • July 9th, 2024 • Pharmaceutical preparations • New York
The purpose of this letter (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by Soligenix, Inc., a Delaware corporation (the “Company”), to render Financial Services (as defined below) to the Company.
